As a -glutamyl cyclotransferase, CHAC1 degrades glutathione, affecting calcium signaling and mitochondrial function
Similar content being viewed by others Introduction Amid the continuously increasing global incidence of diabetes, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a cornerstone in type 2 diabetes treatment, demonstrating remarkable efficacy in glycemic control and cardiovascular risk reduction [1, 2]
The gradual dose escalation protocol used in trials helped minimise the severity and duration of these effects, similar to the approach used with currently available treatments
Our detailed guide on tirzepatide while breastfeeding covers the available evidence in full
[15] [18] For borderline results, additional tests such as methylmalonic acid, homocysteine, or holotranscobalamin may be considered